Navidea Biopharmaceuticals competitors

Navidea Biopharmaceuticals Competitors include Adaptive Biotechnologies, Opko Health, Interpace Diagnostics and MetaboGen AB.
Add company...
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents.
Adaptive Biotechnologies
Adaptive Biotechnologies
Adaptive Biotechnologies offers research and diagnostic tools for scientists and clinicians involved in genomic immunology.
Opko Health
Opko Health
Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
Interpace Diagnostics
Interpace Diagnostics
Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies.
MetaboGen AB
MetaboGen AB
As a pioneering company, MetaboGen is addressing the microbiome to understand health and disease.
Founding Date
Founding Date
1983
Founding Date
2009
Founding Date
2007
Founding Date
1987
Founding Date
2011
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Dublin, US HQ
Locations
Seattle, US HQ
South San Francisco, US
Locations
Miami, US HQ
Woburn, US
Locations
Parsippany-Troy Hills, US HQ
Locations
Landala, SE HQ
Employees
Employees
1914% decrease
Employees
2741% increase
Employees
6,041
Employees
61
Employees
2
Valuation ($)
Valuation ($)
33.6 m
Valuation ($)
1.1 b
Valuation ($)
2 b
Valuation ($)
30.9 m
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
2.3 k
Twitter followers
N/A
Twitter followers
142
Twitter followers
37

Financial

Revenue (est.)
Revenue (est.)
$1.8m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$1.1b (FY, 2017)
Revenue (est.)
$15.9m (FY, 2017)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$3.7k (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$7.4m (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
$1.8m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
$8.5m (FY, 2017)
Gross profit
N/A
Net income
Net income
$74.9m (FY, 2017)
Net income
N/A
Net income
($308.9m) (FY, 2017)
Net income
($12.2m) (FY, 2017)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 539m
Total funding raised
$ 31m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Adaptive Biotechnologies
HQ
Seattle, US
Employees
274↑ 1% increase

Adaptive Biotechnologies offers research and diagnostic tools for scientists and clinicians involved in genomic immunology.

View company
Opko Health
HQ
Miami, US
Employees
6,041

Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.

View company
Interpace Diagnostics
HQ
Parsippany-Troy Hills, US
Employees
61

Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies.

View company
MetaboGen AB
HQ
Landala, SE
Employees
2

As a pioneering company, MetaboGen is addressing the microbiome to understand health and disease.

View company